20 research outputs found

    The zoonotic potential of Clostridium difficile from small companion animals and their owners

    Get PDF
    Background: Clostridium difficile infections (CDI) in humans range from asymptomatic carriage to life-threatening intestinal disease. Findings on C. difficile in various animal species and an overlap in ribotypes (RTs) suggest potential zoonotic transmission. However, the impact of animals for human CDI remains unclear. Methods: In a large-scale survey we collected 1,447 fecal samples to determine the occurrence of C. difficile in small companion animals (dogs and cats) and their owners and to assess potential epidemiological links within the community. The Germany-wide survey was conducted from July 2012-August 2013. PCR ribotyping, Multilocus VNTR Analysis (MLVA) and PCR detection of toxin genes were used to characterize isolated C. difficile strains. A database was defined and logistic regression used to identify putative factors associated with fecal shedding of C. difficile. Results: In total, 1,418 samples met the inclusion criteria. The isolation rates for small companion animals and their owners within the community were similarly low with 3.0% (25/840) and 2.9% (17/578), respectively. PCR ribotyping revealed eight and twelve different RTs in animals and humans, respectively, whereas three RTs were isolated in both, humans and animals. RT 014/0, a well-known human hospital-associated lineage, was predominantly detected in animal samples. Moreover, the potentially highly pathogenic RTs 027 and 078 were isolated from dogs. Even though, C. difficile did not occur simultaneously in animals and humans sharing the same household. The results of the epidemiological analysis of factors associated with fecal shedding of C. difficile support the hypothesis of a zoonotic potential. Conclusions: Molecular characterization and epidemiological analysis revealed that the zoonotic risk for C. difficile associated with dogs and cats within the community is low but cannot be excluded

    Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer’s Disease

    Get PDF
    Yokukansan (YKS) is a traditional Japanese herbal medicine that has been used in humans for the treatment of several neurological conditions, such as age-related anxiety and behavioral and psychological symptoms (BPSD) related to multiple forms of dementia, including Alzheimer’s disease (AD). However, the cellular and molecular mechanisms targeted by YKS in the brain are not completely understood. Here, we compared the efficacy of YKS in ameliorating the age- and early-onset familial AD-related behavioral and cellular defects in two groups of animals: 18- to 22-month-old C57BL6/J wild-type mice and 6- to 9-month-old 5xFAD mice, as a transgenic mouse model of this form of AD. Animals were fed food pellets that contained YKS or vehicle. After 1–2 months of YKS treatment, we evaluated the cognitive improvements in both the aged and 5xFAD transgenic mice, and their brain tissues were further investigated to assess the molecular and cellular changes that occurred following YKS intake. Our results show that both the aged and 5xFAD mice exhibited impaired behavioral performance in novel object recognition and contextual fear conditioning (CFC) tasks, which was significantly improved by YKS. Further analyses of the brain tissue from these animals indicated that in aged mice, this improvement was associated with a reduction in astrogliosis, microglia activation and downregulation of the extracellular matrix (ECM), whereas in 5xFAD mice, none of these mechanisms were evident. These results show the differential action of YKS in healthy aged and 5xFAD mice. However, both aged and 5xFAD YKS-treated mice showed increased neuroprotective signaling through protein kinase B/Akt as the common mode of action. Our data suggest that YKS may impart its beneficial effects through Akt signaling in both 5xFAD mice and aged mice, with multiple additional mechanisms potentially contributing to its beneficial effects in aged animals

    Untersuchung zur PrÀvalenz und DNA-Microarray-basierende Typisierung von Clostridium difficile bei Heim- und Nutztieren

    No full text
    Clostridium (C.) difficile ist beim Menschen ein bedeutender Erreger von Krankenhaus-assoziierten Durchfallerkrankungen. Die vorliegende Dissertation umfasst die Erhebung und Analyse der ersten epidemiologischen Daten zu C. difficile in deutschen Heim- und NutztierbestĂ€nden und die Entwicklung eines neuartigen DNA-Microarrays, der eine einfache Ribotypisierung von C. difficile ermöglicht. In drei Studien wurden Kotproben von Hunden, Katzen, Ferkeln und KĂ€lbern kulturell auf C. difficile untersucht. Das Bakterium wurde aus 5 von 135 Katzenkot- (3,7%), 9 von 165 Hundekot- (5,4%), 176 von 999 KĂ€lberkot- (17,6%) und 147 von 201 Schweinekotproben (73,1%) isoliert. Neugeborene Ferkel und KĂ€lber waren in den ersten 2 bzw. 3 Lebenswochen signifikant hĂ€ufiger kulturpositiv fĂŒr C. difficile als Ă€ltere Tiere. Die in den Studien isolierten StĂ€mme wurden 25 Ribotypen zugeordnet; darunter befanden sich 6 bisher nicht beschriebene Varianten. Bei den Ferkelproben dominierten die einander sehr Ă€hnlichen Ribotypen 078 (55% der Isolate) und 126 (20%). Die Ribotypen 033 (57% der Isolate) und 078 (17%) wurden bei KĂ€lbern am hĂ€ufigsten vorgefunden. Basierend auf ihren Typisierungsprofilen wurden die Ribotypen in einer UPGMA-Analyse (Unweighted Pair Group Method with Arithmetic mean) untereinander verglichen. Von den 25 bei den untersuchten Tieren gefundenen Ribotypen formten 11 einen Cluster, zu dem auch die Ribotypen 033, 078 und 126 gehörten und in dem sich 90% aller in den beiden Nutztierstudien isolierten StĂ€mme wiederfanden. Alle Isolate dieses Clusters waren zudem PCR-positiv fĂŒr ein binĂ€res Toxin und, im Gegensatz zu allen nicht zu dem Cluster gehörenden Ribotypen, PCR-negativ fĂŒr den MLVA-Lokus A6Cd. Hierdurch, aber auch durch frĂŒhere Studien, in denen gezeigt werden konnte, dass die dem Cluster zugeordneten Ribotypen 033, 045, 078 und 126 den gleichen MLST-Typ (ST-11, Multilocus Sequence Typing) und eine charakteristische Deletion (delta 39 bp) im Toxinregulatorgen tcdC aufweisen, wird die These einer genetische Verwandtschaft unterstĂŒtzt. In allen untersuchten Tierpopulationen wurden Ribotypen gefunden, die mit C.-difficile-Infektionen des Menschen assoziiert werden. Da StĂ€mme des Ribotyps 078 in deutschen und europĂ€ischen KrankenhĂ€usern zunehmend hĂ€ufiger als Ursache von Durchfallerkrankungen auftreten, wurden alle ermittelten MLVA-Daten von Ribotyp-078-StĂ€mmen humanen und tierischen Ursprungs mit entsprechenden Daten anderer Studien aus 5 europĂ€ischen LĂ€ndern verglichen. In einer hierbei durchgefĂŒhrten Minimum-Spanning-Tree-Analyse mit 294 DatensĂ€tzen wurde die genetische Abgrenzung von MLVA-Typen unterschiedlicher geographischer Herkunft verdeutlicht und belegt, dass einige aus Tieren und Menschen isolierte C.-difficile-StĂ€mme sehr Ă€hnlichen oder sogar identischen MLVA-Typen entsprechen. Die in den Haus- und Nutztierstudien isolierten C. difficile wurden anschließend mit dem neu entwickelten DNA-Microarray ribotypisiert. Das Sondendesign des Microarrays basiert auf der bei C. difficile modular aufgebauten Intergenic Spacer Region (ISR), welche auch Zielstruktur der herkömmlichen Ribotypisierungsmethoden ist. Die Sonden wurden von in der GenBank-Datenbank publizierten ISR-Modulsequenzen und theoretisch möglichen Modulsequenzkombinationen abgeleitet. Nachdem die Eignung des Arrays in theoretisch und praktisch durchgefĂŒhrten Experimenten belegt werden konnte, wurde mit 142 reprĂ€sentativ ausgewĂ€hlten C.-difficile-StĂ€mmen eine 48 Ribotypen umfassende Datenbank aus Referenzhybridisierungsmustern erstellt. Diese Referenzmuster wurden anschließend in einer Ähnlichkeitsmatrix-Analyse untereinander verglichen, wobei 27 Referenzmuster eindeutig differenziert werden konnten. Zu den gut unterscheidbaren Ribotypen gehörten u.a. die hĂ€ufig mit humanen C.-difficile-Infektionen assoziierten Ribotypen 001, 014/020, 027 und 078/126. Nicht unterscheidbar hingegen waren die 11 Ribotypen des oben beschriebenen Clusters, wodurch sich die These ihrer molekularen Verwandtschaft weiter erhĂ€rtet. Die Praxistauglichkeit des DNA-Microarrays wurde abschließend in einer Anwendungsstudie ĂŒberprĂŒft. Hierbei wurden 50 C.-difficile-StĂ€mme, die im Rahmen eines anderen Projektes aus Kotproben von Haustieren und deren Besitzern isoliert wurden, mit herkömmlicher und DNA-Microarray-basierter Ribotypisierung vergleichend untersucht. BerĂŒcksichtig man, dass durch den Microarray einige sehr Ă€hnliche Ribotypen derzeit noch nicht unterschieden werden können, wurden alle Isolate dem richtigen Ribotypen bzw. der richtigen Ribotypengruppe zugeordnet. DarĂŒber hinaus wurden 6 fĂŒr das Microarray unbekannte Ribotypen korrekt als „neu“ und klar voneinander unterscheidbar erkannt. Zusammenfassend trĂ€gt das Dissertationsprojekt zum VerstĂ€ndnis ĂŒber das Vorkommen von C.-difficile-Genotypen in Heim- und NutztierbestĂ€nden bei und prĂ€sentiert einen neuartigen DNA-Microarray zur einfachen Ribotypisierung von C. difficile.Clostridium (C.) difficile is the leading infectious agent of nosocomial diarrhea in humans. This dissertation comprises studies on the presence and diversity of C. difficile in German farm and companion animals and describes the development of a DNA microarray based assay for efficient and reliable PCR ribotyping of C. difficile strains on a convenient laboratory platform. In three studies, faecal samples from dogs, cats, piglets and calves were examined using direct plating and enrichment culture in parallel. C. difficile isolated in these studies were characterized by toxin gene PCR (tcdA, tcdB, cdtA, and cdtB), multiple-locus VNTR analysis (MLVA), capillary gel electrophoresis-based PCR ribotyping (seq-PCR ribotyping) and by the new DNA microarray assay. C. difficile was isolated from 5 of 135 (3.7%) feline, 9 of 165 (5.4%) canine, 176 of 999 (17.6%) bovine and 147 of 201 (73.1%) porcine samples. The prevalence’s found for piglets and calves of 4 weeks of age and older were significantly lower than for younger animals. Strains isolated in these studies were assigned to 25 PCR ribotypes, including 6 PCR ribotypes that have not been previously described. The closely related PCR ribotypes 078 (55%) and 126 (20%) were most frequently found in porcine samples while PCR ribotypes 033 (57%) and 078 (17%) were predominant in the calve samples. Strains of PCR ribotypes, previously described to be human pathogenic (e.g. 014, 078, 126, and 023) were found in all investigated species. Neighbourhood analysis (UPGMA, Unweighted Pair Group Method with Arithmetic mean) based on the PCR ribotype peak pattern revealed a clusters with 11 related PCR ribotypes that differed significantly from the other detected PCR ribotypes. This cluster comprised i. a. PCR ribotypes 033, 045, 078 and 126 and accounted for 90% of all C. difficile strains isolated from farm animals. Molecular relatedness was supported by the absence of the MLVA locus A6Cd only in clustered strains and identical toxin gene profiles. Previously reported multilocus sequence typing analysis found an identical sequence type (ST-11) and a tcdC deletion (delta 39 bp) for PCR ribotypes 033, 045, 078 and 126, confirming the clustering. PCR ribotype 078 is increasingly being recognized as a cause of human infections. Therefore, data for isolates of this ribotype recovered during the dissertation (including isolates of human CDI patients) were compared to previous published MLVA data, including porcine, human, and bovine C. difficile isolates from 5 European countries. The calculated minimum spanning tree of 294 European C. difficile isolates of PCR ribotype 078 revealed genetic differences between strains of European countries and also confirmed that some human and porcine isolates are genetically closely related. C. difficile strains isolated in the livestock and shelter studies were subsequently PCR ribotyped using the developed DNA microarray assay. Hybridization probes were designed to query the modularly structured intergenic spacer region (ISR), which is also the template for conventional and PCR ribotyping with subsequent capillary gel electrophoresis (seq-PCR) ribotyping. The probes were derived from sequences available in GenBank as well as from theoretical ISR module combinations. A database of reference hybridization patterns was set up from a collection of 142 well-characterized C. difficile isolates representing 48 seq-PCR ribotypes. The reference hybridization patterns calculated by the arithmetic mean were compared using a similarity matrix analysis. The 48 investigated seq-PCR ribotypes revealed 27 array profiles that were clearly distinguishable. The most frequent human-pathogenic ribotypes 001, 014/020, 027, and 078/126 were discriminated by the microarray. C. difficile strains related to 078/126 (033, 045/FLI01, 078, 126, 126/FLI01, 413, 413/FLI01, 598, 620, 652, and 660) and 014/020 (014, 020, and 449) showed similar hybridization patterns, confirming their genetic relatedness, which was reported in the prevalence studies. A panel of 50 C. difficile field isolates was tested by seq-PCR ribotyping and the DNA microarray-based assay in parallel. Taking into account that the current version of the microarray does not discriminate some closely related seq-PCR ribotypes, all isolates were typed correctly. Moreover, seq-PCR ribotypes without reference profiles available in the database (ribotype 009 and 5 new types) were correctly recognized as new ribotypes, confirming the performance and expansion potential of the microarray. In summary, the dissertation showed that German farm and companion animals are potential reservoirs of emerging human pathogenic C. difficile PCR ribotypes and presented the first DNA microarray-based assay for rapid PCR ribotyping of C. difficile

    Traditional Japanese Herbal Medicine Yokukansan Targets Distinct but Overlapping Mechanisms in Aged Mice and in the 5xFAD Mouse Model of Alzheimer’s Disease

    No full text
    Yokukansan (YKS) is a traditional Japanese herbal medicine that has been used in humans for the treatment of several neurological conditions, such as age-related anxiety and behavioral and psychological symptoms (BPSD) related to multiple forms of dementia, including Alzheimer’s disease (AD). However, the cellular and molecular mechanisms targeted by YKS in the brain are not completely understood. Here, we compared the efficacy of YKS in ameliorating the age- and early-onset familial AD-related behavioral and cellular defects in two groups of animals: 18- to 22-month-old C57BL6/J wild-type mice and 6- to 9-month-old 5xFAD mice, as a transgenic mouse model of this form of AD. Animals were fed food pellets that contained YKS or vehicle. After 1–2 months of YKS treatment, we evaluated the cognitive improvements in both the aged and 5xFAD transgenic mice, and their brain tissues were further investigated to assess the molecular and cellular changes that occurred following YKS intake. Our results show that both the aged and 5xFAD mice exhibited impaired behavioral performance in novel object recognition and contextual fear conditioning (CFC) tasks, which was significantly improved by YKS. Further analyses of the brain tissue from these animals indicated that in aged mice, this improvement was associated with a reduction in astrogliosis, microglia activation and downregulation of the extracellular matrix (ECM), whereas in 5xFAD mice, none of these mechanisms were evident. These results show the differential action of YKS in healthy aged and 5xFAD mice. However, both aged and 5xFAD YKS-treated mice showed increased neuroprotective signaling through protein kinase B/Akt as the common mode of action. Our data suggest that YKS may impart its beneficial effects through Akt signaling in both 5xFAD mice and aged mice, with multiple additional mechanisms potentially contributing to its beneficial effects in aged animals

    Synaptic Remodeling Depends on Signaling between Serotonin Receptors and the Extracellular Matrix

    No full text
    Rewiring of synaptic circuitry pertinent to memory formation has been associated with morphological changes in dendritic spines and with extracellular matrix (ECM) remodeling. Here, we mechanistically link these processes by uncovering a signaling pathway involving the serotonin 5-HT7 receptor (5-HT7R), matrix metalloproteinase 9 (MMP-9), the hyaluronan receptor CD44, and the small GTPase Cdc42. We highlight a physical interaction between 5-HT7R and CD44 (identified as an MMP-9 substrate in neurons) and find that 5-HT7R stimulation increases local MMP-9 activity, triggering dendritic spine remodeling, synaptic pruning, and impairment of long-term potentiation (LTP). The underlying molecular machinery involves 5-HT7R-mediated activation of MMP-9, which leads to CD44 cleavage followed by Cdc42 activation. One important physiological consequence of this interaction includes an increase in neuronal outgrowth and elongation of dendritic spines, which might have a positive effect on complex neuronal processes (e.g., reversal learning and neuronal regeneration)
    corecore